Concepedia

Sarah C. Hobbs

SC

Statistics

Publications

11

Citations

709

H-Index

11

Active since

1993

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Sarah C. Hobbs is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and neuropharmacology.

Publications per year

1993–2005

11

Publications

11

Identification of a Novel, Selective GABA<sub>A</sub>α5 Receptor Inverse Agonist Which Enhances Cognition

Mark S. Chambers, John Atack, Howard B. Broughton et al. · Journal of Medicinal Chemistry · 2003 · 140 citations · Full text

, , +16

Total Synthesis and Determination of the Absolute Configuration of Epibatidine

Stephen R. Fletcher, Raymond Baker, Mark S. Chambers et al. · The Journal of Organic Chemistry · 1994 · 124 citations

, , +9

An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABA<sub>A</sub> α5 Receptors with Cognition Enhancing Properties

Mark S. Chambers, John Atack, Robert W. Carling et al. · Journal of Medicinal Chemistry · 2004 · 108 citations · Full text

, , +15

Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors

Leslie J. Street, R. BAKER, José L. Castro et al. · Journal of Medicinal Chemistry · 1993 · 75 citations · Full text

, , +15

The synthesis of (+)- and (–)-epibatidine

Stephen R. Fletcher, Raymond Baker, Mark S. Chambers et al. · Journal of the Chemical Society Chemical Communications · 1993 · 70 citations

, , +5

1–5 of 11